As of April 1, 2017

Top Management Divisional/Functional Responsibilities
Yoshihiko Hatanaka
Chief Executive Officer		 Internal Auditing, External Relations, Drug Discovery Research, Pharmaceutical Technology,Legal, Intellectual Property, Astellas Institute for Regenerative Medicine
Kenji Yasukawa
Chief Strategy Officer & Chief Commercial Officer		 Corporate Planning, Product & Portfolio Strategy, Business Development, Japan Sales & Marketing, Asia & Oceania Business, Europe, Middle East and Africa Operations, Americas Operations, Marketing Strategy
Sef Kurstjens
Chief Medical Officer		 Development, Pharmacovigilance, Medical Affairs, Regulatory Affairs, Clinical and Research Quality Assurance, Quality Assurance
Chikashi Takeda
Chief Financial Officer		 Corporate Finance & Control, Accounting & Tax, Corporate Communications, Procurement, Information Systems, Real World Informatics and Analytics
Fumiaki Sakurai
Chief Administrative Officer & Chief Ethics & Compliance Office		 Healthcare Policy & CSR, General Affairs, Human Resources, Ethics & Compliance, Executive Office

Extended Members of Executive Committee

Standing Members
Chief Executive Officer Yoshihiko Hatanaka
Chief Strategy Officer & Chief Commercial Officer Kenji Yasukawa
Chief Medical Officer Sef Kurstjens
Chief Financial Officer Chikashi Takeda
Chief Administrative Officer &
Chief Ethics & Compliance Officer		 Fumiaki Sakurai
General Counsel Linda Friedman
Extended Members
President, Japan Sales & Marketing Nobuaki Tanaka
President, Asia & Oceania Business Masatoshi Kuroda
President, Americas Operations James Robinson
President, Europe, Middle East and Africa Operations Yukio Matsui
President, Drug Discovery Research Wataru Uchida
President, Pharmaceutical Technology Mitsunori Matsuda
President, Development Bernie Zeiher